Literature DB >> 29099306

eIF3: a factor for human health and disease.

Andreia Gomes-Duarte1,2, Rafaela Lacerda1,2, Juliane Menezes1,2, Luísa Romão1,2.   

Abstract

The eukaryotic initiation factor 3 (eIF3) is one of the most complex translation initiation factors in mammalian cells, consisting of several subunits (eIF3a to eIF3m). It is crucial in translation initiation and termination, and in ribosomal recycling. Accordingly, deregulated eIF3 expression is associated with different pathological conditions, including cancer. In this manuscript, we discuss the interactome and function of each subunit of the human eIF3 complex. Furthermore, we review how altered levels of eIF3 subunits correlate with neurodegenerative disorders and cancer onset and development; in addition, we evaluate how such misregulation may also trigger infection cascades. A deep understanding of the molecular mechanisms underlying eIF3 role in human disease is essential to develop new eIF3-targeted therapeutic approaches and thus, overcome such conditions.

Entities:  

Keywords:  Cancer; eIF3; infection; neurodegenerative disease; translation; translation initiation factor; translational control

Mesh:

Substances:

Year:  2017        PMID: 29099306      PMCID: PMC5785978          DOI: 10.1080/15476286.2017.1391437

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  117 in total

1.  Structure of a yeast 40S-eIF1-eIF1A-eIF3-eIF3j initiation complex.

Authors:  Christopher H S Aylett; Daniel Boehringer; Jan P Erzberger; Tanja Schaefer; Nenad Ban
Journal:  Nat Struct Mol Biol       Date:  2015-02-09       Impact factor: 15.369

2.  Decreased expression of eukaryotic initiation factor 3f deregulates translation and apoptosis in tumor cells.

Authors:  J Shi; A Kahle; J W B Hershey; B M Honchak; J A Warneke; S P L Leong; M A Nelson
Journal:  Oncogene       Date:  2006-03-13       Impact factor: 9.867

3.  Possible involvement of a mitochondrial translation initiation factor 3 variant causing decreased mRNA levels in Parkinson's disease.

Authors:  Anna Anvret; Caroline Ran; Marie Westerlund; Ann-Christin Thelander; Olof Sydow; Charlotta Lind; Anna Håkansson; Hans Nissbrandt; Dagmar Galter; Andrea Carmine Belin
Journal:  Parkinsons Dis       Date:  2010-06-14

4.  Association of cap-binding protein with eucaryotic initiation factor 3 in initiation factor preparations from uninfected and poliovirus-infected HeLa cells.

Authors:  J Hansen; D Etchison; J W Hershey; E Ehrenfeld
Journal:  J Virol       Date:  1982-04       Impact factor: 5.103

5.  Loss of the eukaryotic initiation factor 3f in pancreatic cancer.

Authors:  Adriana Doldan; Anupama Chandramouli; Reneé Shanas; Achyut Bhattacharyya; John T Cunningham; Mark A Nelson; Jiaqi Shi
Journal:  Mol Carcinog       Date:  2008-03       Impact factor: 4.784

6.  Role of eIF3 p170 in controlling synthesis of ribonucleotide reductase M2 and cell growth.

Authors:  Zizheng Dong; Lisa H Liu; Baoguang Han; Roxana Pincheira; Jian-Ting Zhang
Journal:  Oncogene       Date:  2004-05-06       Impact factor: 9.867

7.  eIF3a is over-expressed in urinary bladder cancer and influences its phenotype independent of translation initiation.

Authors:  Rita Spilka; Christina Ernst; Helmut Bergler; Johannes Rainer; Susanne Flechsig; Alexander Vogetseder; Eva Lederer; Martin Benesch; Andrea Brunner; Stephan Geley; Andreas Eger; Felix Bachmann; Wolfgang Doppler; Peter Obrist; Johannes Haybaeck
Journal:  Cell Oncol (Dordr)       Date:  2014-07-29       Impact factor: 6.730

8.  Identification of a 170-kDa protein over-expressed in lung cancers.

Authors:  R Pincheira; Q Chen; J T Zhang
Journal:  Br J Cancer       Date:  2001-06-01       Impact factor: 7.640

9.  The indispensable N-terminal half of eIF3j/HCR1 cooperates with its structurally conserved binding partner eIF3b/PRT1-RRM and with eIF1A in stringent AUG selection.

Authors:  Latifa Elantak; Susan Wagner; Anna Herrmannová; Martina Karásková; Edit Rutkai; Peter J Lukavsky; Leos Valásek
Journal:  J Mol Biol       Date:  2010-01-11       Impact factor: 5.469

10.  Architecture of human translation initiation factor 3.

Authors:  Jordi Querol-Audi; Chaomin Sun; Jacob M Vogan; M Duane Smith; Yu Gu; Jamie H D Cate; Eva Nogales
Journal:  Structure       Date:  2013-04-25       Impact factor: 5.006

View more
  25 in total

1.  circPDE5A regulates prostate cancer metastasis via controlling WTAP-dependent N6-methyladenisine methylation of EIF3C mRNA.

Authors:  Lifeng Ding; Ruyue Wang; Qiming Zheng; Danyang Shen; Huan Wang; Zeyi Lu; Wenqin Luo; Haiyun Xie; Liangliang Ren; Minxiao Jiang; Chenhao Yu; Zhenwei Zhou; Yudong Lin; Haohua Lu; Dingwei Xue; Wenjing Su; Liqun Xia; Jochen Neuhaus; Sheng Cheng; Gonghui Li
Journal:  J Exp Clin Cancer Res       Date:  2022-06-02

2.  Circ_0085315 promotes cell proliferation, invasion, and migration in colon cancer through miR-1200/MAP3K1 signaling pathway.

Authors:  Yuan Luo; Qi Yao
Journal:  Cell Cycle       Date:  2022-03-01       Impact factor: 5.173

3.  METTL16 exerts an m6A-independent function to facilitate translation and tumorigenesis.

Authors:  Rui Su; Lei Dong; Yangchan Li; Min Gao; P Cody He; Wei Liu; Jiangbo Wei; Zhicong Zhao; Lei Gao; Li Han; Xiaolan Deng; Chenying Li; Emily Prince; Brandon Tan; Ying Qing; Xi Qin; Chao Shen; Meilin Xue; Keren Zhou; Zhenhua Chen; Jianhuang Xue; Wei Li; Hanjun Qin; Xiwei Wu; Miao Sun; Yunsun Nam; Chun-Wei Chen; Wendong Huang; David Horne; Steven T Rosen; Chuan He; Jianjun Chen
Journal:  Nat Cell Biol       Date:  2022-02-10       Impact factor: 28.213

4.  Translational regulation of Chk1 expression by eIF3a via interaction with the RNA-binding protein HuR.

Authors:  Zizheng Dong; Jianguo Liu; Jian-Ting Zhang
Journal:  Biochem J       Date:  2020-05-29       Impact factor: 3.857

5.  Conformational rearrangements upon start codon recognition in human 48S translation initiation complex.

Authors:  Sung-Hui Yi; Valentyn Petrychenko; Jan Erik Schliep; Akanksha Goyal; Andreas Linden; Ashwin Chari; Henning Urlaub; Holger Stark; Marina V Rodnina; Sarah Adio; Niels Fischer
Journal:  Nucleic Acids Res       Date:  2022-05-20       Impact factor: 16.971

Review 6.  Translational control in aging and neurodegeneration.

Authors:  Geena Skariah; Peter K Todd
Journal:  Wiley Interdiscip Rev RNA       Date:  2020-09-20       Impact factor: 9.349

7.  eIF-Three to Tango: emerging functions of translation initiation factor eIF3 in protein synthesis and disease.

Authors:  Dieter A Wolf; Yingying Lin; Haoran Duan; Yabin Cheng
Journal:  J Mol Cell Biol       Date:  2020-07-03       Impact factor: 6.216

8.  The allotetraploid origin and asymmetrical genome evolution of the common carp Cyprinus carpio.

Authors:  Peng Xu; Jian Xu; Guangjian Liu; Lin Chen; Zhixiong Zhou; Wenzhu Peng; Yanliang Jiang; Zixia Zhao; Zhiying Jia; Yonghua Sun; Yidi Wu; Baohua Chen; Fei Pu; Jianxin Feng; Jing Luo; Jing Chai; Hanyuan Zhang; Hui Wang; Chuanju Dong; Wenkai Jiang; Xiaowen Sun
Journal:  Nat Commun       Date:  2019-10-11       Impact factor: 14.919

9.  Binding of eIF3 in complex with eIF5 and eIF1 to the 40S ribosomal subunit is accompanied by dramatic structural changes.

Authors:  Jakub Zeman; Yuzuru Itoh; Zdeněk Kukačka; Michal Rosůlek; Daniel Kavan; Tomáš Kouba; Myrte E Jansen; Mahabub P Mohammad; Petr Novák; Leoš S Valášek
Journal:  Nucleic Acids Res       Date:  2019-09-05       Impact factor: 16.971

10.  Eukaryotic initiation factor EIF-3.G augments mRNA translation efficiency to regulate neuronal activity.

Authors:  Stephen M Blazie; Seika Takayanagi-Kiya; Katherine A McCulloch; Yishi Jin
Journal:  Elife       Date:  2021-07-29       Impact factor: 8.713

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.